RFP
CRDF icon

Root Financial Partners’s Cardiff Oncology CRDF Stock Holding History

Root Financial Partners’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$154 Buy
+95
New +$195 ﹤0.01% 3205

Other funds holding CRDF

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

Root Financial Partners's CRDF Position: Q1 2026 in Review

Root Financial Partners opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 95 shares worth $154. The stake represents ﹤0.01% of the portfolio and ranks #3205 among its holdings.

116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

  • Root Financial Partners held 95 shares of Cardiff Oncology worth $154 as of Q1 2026.
  • Cardiff Oncology was a new Root Financial Partners position in Q1 2026.
  • Cardiff Oncology made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #3205 holding.
  • 116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.